24 July 2026
Latham Represents Warburg Pincus‑Led Investor Group in Investment in Paradigm Oral Health’s Surgeon‑Led Buyback
Advising firms
Deal team
35 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Stelios Saffos Lead | Latham & Watkins LLP | Partner | Capital Markets and Hybrid Capital | Not stated |
| John Sobolewski | Latham & Watkins LLP | Partner | Liability Management | Not stated |
| Peter Sluka | Latham & Watkins LLP | Partner | Hybrid Capital | Not stated |
| John Miller | Latham & Watkins LLP | Partner | Hybrid Capital | Not stated |
| Andrew Blumenthal | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Haim Zaltzman | Latham & Watkins LLP | Partner | Emerging Companies & Growth | Not stated |
| Nima Movahedi | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Ben Gelfand | Latham & Watkins LLP | Counsel | Not stated | Not stated |
| Claire Solimine | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Ian Lachow | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Adam Weber | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Yulong Li | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Sam Berry | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Gordon Wilford | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Cherrie Wang | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Caleb King | Latham & Watkins LLP | Not stated | Not stated | Not stated |
| Jackson Davenport | Latham & Watkins LLP | Not stated | Not stated | Not stated |
| Pardis Zomorodi | Latham & Watkins LLP | Partner | tax | Not stated |
| Eric Kamerman | Latham & Watkins LLP | Partner | tax | Not stated |
| Arash Lotfi | Latham & Watkins LLP | Associate | tax | Not stated |
| Joyce Shin | Latham & Watkins LLP | Associate | tax | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Not stated |
| Yanyan Zhou | Latham & Watkins LLP | Counsel | healthcare regulatory | Not stated |
| Aaron Tso | Latham & Watkins LLP | Associate | executive compensation and benefits | Not stated |
| Sandra Benjamin | Latham & Watkins LLP | Partner | labor and employment | Not stated |
| Alexis Pinzon | Latham & Watkins LLP | Associate | labor and employment | Not stated |
| Lauren Stark | Latham & Watkins LLP | Associate | labor and employment | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | healthcare data privacy | Not stated |
| Chad Leiper | Latham & Watkins LLP | Associate | healthcare data privacy | Not stated |
| Deborah Hinck | Latham & Watkins LLP | Partner | intellectual property | Not stated |
| Daniel Barks | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Betty Huber | Latham & Watkins LLP | Partner | ESG | Not stated |
| Sophia Fossali | Latham & Watkins LLP | Associate | ESG | Not stated |
| Shira Bressler | Latham & Watkins LLP | Counsel | real estate | Not stated |
| Brandon Hemans | Latham & Watkins LLP | Associate | real estate | Not stated |
32 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Warburg Pincus (Investor)
Goldman Sachs Alternatives (Investor)
Sixth Street (Investor)
BlackRock Long Term Private Capital (Sell-side)
Paradigm Oral Health (Target)